Episurf Medical
New patent approvals for Episurf Medical
Episurf Medical (NASDAQ: EPIS B) has during the last months received four additional patent approval notifications. The Indian patent office Intellectual Property India has reported that Episurf has received two new granted patents in India. One is related to implant materials and coatings, while the other is related to Episurf's damage visualisation process for surgical pre-planning and individualised medical device design. The Australian patent office IP Australia has issued a notice of acceptance for a patent related to the implant-specific drill used for Episurf's implant technology. Lastly, the Companies and Intellectual Property Commission of South Africa has granted Episurf its first ever patent in South Africa. That patent covers a system for customising an implant for treatment of damage in an anatomical joint.
"As we take new steps towards new global markets, we also take care to protect our technology. While we are at an early stage in Australia and South Africa, India is currently a highly prioritised country for Episurf. A number of surgeries with Episurf's Episealer® implants have taken place there during this year, and the increased patent protection there is appreciated to strengthen our position in this highly interesting market", comments Katarina Flodström, COO, Episurf Medical.
Datum | 2023-11-28, kl 08:30 |
Källa | Cision |
![](https://static.allaaktier.se/ads/hand-waving-2.png)